Is there any available literature that describes, in depth, rubella antiserum titers that successfully block rubella when measuring measles potency via the TCID50 assay in a combination MR vaccine?
Information on the specific antiserum titers required to successfully block rubella in a combined MR vaccine might be limited. You could explore vaccine development journals, pharmacology textbooks, or consult experts in immunology or vaccine development for more insight.